USC removes name of Rufus von KleinSmid, a eugenics leader, from prominent building
By Teresa Watanabe and Tomás Mier,
Los Angeles Times
| 06. 12. 2020
The scholar, who is credited with expanding the university’s academic programs and international relations curriculum as president from 1921 to 1947, believed that people with “defects” had no ethical right to parenthood and should be sterilized.
With its soaring arches, international flags and globe-topped tower, the Von KleinSmid Center for International and Public Affairs is one of the most prominent buildings at USC. Its namesake, the late Rufus B. von KleinSmid, has held a place of distinction as the university’s fifth president.
But on Thursday, USC announced it had stripped Von KleinSmid’s name from the building as the university at last reconciled with his disturbing leadership role in California’s eugenics movement.
The scholar, who is credited with expanding the university’s academic programs and international relations curriculum as president from 1921 to 1947, believed that people with “defects” had no ethical right to parenthood and should be sterilized. His “Human Betterment Foundation” was instrumental in supporting the 1909 California legislation that authorized the forced sterilization of those deemed “unfit” — essentially anyone non-white, said Alexandra Minna Stern, a University of Michigan history professor and expert on eugenics.
His active support of eugenics is “at direct odds with USC’s multicultural community and our mission of diversity and inclusion,” President Carol L. Folt announced.
“This moment is our Call...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...